Ocular bacterial keratitis, often associated with Pseudomonas aeruginosa bacterial infection, commonly occurs in contact lens wearers and may lead to vision impairment. In this study, we analyzed the contribution of neutrophil extracellular traps (NETs) to the mediation of protection during ocular keratitis. Both invasive and cytotoxic P. aeruginosa clinical isolates induced NET release by neutrophils. NETs carried the characteristic histone proteins, elastase, lysozyme, myeloperoxidase, and metabolic enzymes. While the invasive P. aeruginosa strains PAO1 (serogroup O5) and 6294 (serogroup O6) were trapped by NETs, the cytotoxic P. aeruginosa strains 6077, 6206 (serogroup O11), and PA14 (serogroup 010) were less sensitive to NET capture. The mechanism of escape by the cytotoxic strains from adhesion to NETs involved the shedding of outer membrane vesicles (OMVs) that outcompeted the cytotoxic P. aeruginosa strains for NET binding. When ocular infection was caused by an invasive strain in vivo, NETs were released at the ocular surface to capture bacteria, limiting their spread. Treatment with MNase I had a dose-dependent effect, with low doses of MNase speeding up bacterial clearance and high doses of MNase having toxic consequences. Cumulatively, our data suggest that NET-mediated immunity is a two-step process. Initially, pathogens attach to NET fragments; subsequently, upon nuclease activity, active serine proteases, which proteolytically degrade NET-associated proteins and promote DNase activity, are released. Therefore, a balance between NET production and NET degradation is needed to achieve maximal NET immunity.
I
nfections caused by Pseudomonas aeruginosa are frequently associated with bacterial ocular keratitis, a condition that carries the risk of vision impairment and occurs in contact lens wearers or after ocular trauma. The majority of bacterial clinical isolates derived from corneal ulcers arising during keratitis can be divided into two functionally distinct groups: invasive and cytotoxic isolates. These two groups have distinct phenotypes; the cytotoxic strains cause rapid cell lysis, whereas the invasive strains replicate in the target cells (1, 2) . These differences translate into various severities of disease; in mouse keratitis studies where infection is induced by cytotoxic strains, disease pathology is worse than that caused by invasive strains (3) . Consistent with these findings, patients infected with cytotoxic strains have experienced more severe pathology and, consequently, suffered from greater visual impairment after recovery from infection (4) . The immune response to both invasive and cytotoxic strains is dominated by dense neutrophil infiltrates, yet the infiltration pattern and responses of polymorphonuclear neutrophils (PMNs) differ depending on the type of strain. Due to the recently described ability of neutrophils to release DNA in the form of neutrophil extracellular traps (NETs) (5) and the presence of extracellular DNA during cytotoxic infections, we questioned whether the cytotoxic strains trigger NETosis (5) .
To address this question, we used proteomic approaches to generate a comprehensive list for P. aeruginosa-triggered NET proteomes released in response to either invasive or cytotoxic challenges. We report that the cytotoxic strain PA14 induced release of NET eDNA that was in complex with the characteristic NET proteins. Because NETs contain a range of antimicrobial factors (e.g., histones, defensin, lysozyme, and myeloperoxidase), it is expected that they have bactericidal and fungicidal properties (5) . While Escherichia coli, Klebsiella pneumoniae, and Candida albicans were reported to be sensitive to NET-mediated killing, Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes, Neisseria meningitides, Mycobacterium tuberculosis, Staphylococcus aureus, Staphylococcus epidermidis, and Yersinia pestis were shown to be resistant (6) (7) (8) (9) (10) (11) (12) . Whether NETs trap and kill P. aeruginosa is controversial. We, along with others, reported that the nonmucoid cystic fibrosis-derived P. aeruginosa strains were sensitive to NET trapping while the mucoid strains were resistant (13) (14) (15) . In contrast, Parker et al. reported that P. aeruginosa was not sensitive to NET-mediated killing (16) . Given that the keratitis-associated P. aeruginosa clinical isolates show distinct population characteristics and express virulence factors different from those of the pneumonia isolates, a separate study analyzing their sensitivities to NET capture and killing is warranted (17) . Here, we compared the susceptibility of invasive versus cytotoxic P. aeruginosa clinical isolates to NET-mediated capture and killing. We found that invasive strains were trapped by NETs and were weakly susceptible to NET-mediated killing, whereas the cytotoxic strains were less sensitive to NET capture.
MATERIALS AND METHODS
Bacterial strains. The invasive P. aeruginosa strains PAO1, 6294, and 6354 and the cytotoxic P. aeruginosa strains PA14, 6077, 6073, and 6206 were used throughout these experiments. The PAO1 AKA1401 and PAO1 pLSP2 strains were provided by G. Pier (BWH) (18) . The PAO1 ExoU strain was provided by S. Lory (HMS).
Mice. All animal studies were performed in accordance with guidelines established by the Harvard Medical School Animal Care and Use Committee. The experimental protocols were approved by the Institutional Animal Care and Use Committee of the Harvard Medical Area Office for Research Subject Protection and were consistent with the Association for Research in Vision and Ophthalmology guidelines for studies in animals. Infections were carried out as described previously (19) . Mice were anesthetized with ketamine and xylazine injections. Three 0.5-cm scratches were made on the corneas, and an inoculum of P. aeruginosa 6294 (1 ϫ 10 6 CFU/eye) was delivered in 10 l onto the eye. Mice remained sedated for about 30 min. For evaluation of corneal pathology, daily scores were recorded by an observer who was unaware of the experimental status of the animals. Pathology scores were based on a scoring system using a graded scale of 0 to 4. A score of 0 indicated that the eye was macroscopically identical to the uninfected contralateral control eye. A score of 1 indicated faint opacity partially covering the pupil. A score of 2 indicated dense opacity covering the pupil. A score of 3 indicated dense opacity covering the entire anterior segment, and a score of 4 indicated the perforation of the cornea, phthisis bulbi (shrinkage of the globe after inflammatory disease), or both. To determine the levels of bacteria in the cornea 24 or 48 h after infection, mice were sacrificed, the eyes were enucleated, and corneas were dissected from the ocular surface. To quantify extracellular levels of P. aeruginosa, corneas were excised, suspended in phosphate-buffered saline (PBS), and vortexed. Subsequently, serial dilutions were made and plated on P. aeruginosaselective cetrimide plates.
Increasing concentrations of MNase I (Sigma), ranging from 300 to 5,000 U/cornea, were applied topically every 8 h after the infectious challenge. PBS (MNase I solvent) was administered to the control group.
Isolation of primary human neutrophils. PMNs were isolated from healthy human donors. Blood (10 ml) was drawn from healthy individuals, with their informed consent, using a sodium-heparin blood collection kit (Becton Dickinson Vacutainer Safety-Lok blood collection set). Blood was inverted to mix with the anticoagulant agent. A density gradient was prepared using Polymorph reagent (Axis-Shield) by following instructions provided by the manufacturer. The blood was layered on the gradient and centrifuged at 500 ϫ g for 30 min, at room temperature, using a swing-bucket centrifuge without braking. Purified PMNs were resuspended in 5 ml of Hanks balanced salt solution buffer without Ca 2ϩ or Mg 2ϩ ions (HBSS Ϫ/Ϫ ; Invitrogen, CA). Immediately prior to adding bacteria, PMNs were pelleted at 400 ϫ g for 10 min and resuspended in HBSS with Ca 2ϩ , Mg 2ϩ , and 0.1% gelatin (GHBSS ϩϩ ; Invitrogen). Isolation of primary murine neutrophils. Bone marrow was flushed from femurs and tibias of 6-to 8-week old macrophage inhibitory factor (MIF) knockout mice and C57BL/6 mice. Cells were resuspended in PBS and 5 mM EDTA and centrifuged at 600 ϫ g for 10 min at 4°C. Cell pellets were resuspended in 45% Percoll solution and layered over a gradient composed of 3 ml of 81%, 2 ml of 62%, 2 ml of 55%, and 2 ml of 50% Percoll. The gradient was centrifuged at 1,600 ϫ g for 30 min at 10°C without braking. Cells were collected from the interface of the 81% and 62% layers. Collected cells were washed and resuspended in 3 ml HBSS Ϫ/Ϫ buffer and then layered over 3 ml of Histopaque 1119 to remove remaining red blood cells. This gradient was spun at 1,600 ϫ g for 30 min at 10°C. The supernatant was discarded, and the pelleted cells were resuspended in HBSS Ϫ/Ϫ buffer. Maintenance and differentiation of HL-60 cells. Human promyelocytic leukemia line HL-60 (ATCC line CCL-240) cells were used. A quantity of 1.0 ϫ 10 7 frozen cells was thawed, centrifuged for 5 min at 300 ϫ g, and resuspended in 10 ml of HL-60 growth media containing RPMI with L-glutamine (Invitrogen, CA). The cells were supplemented with 15% heat-inactivated fetal bovine serum (HI-FBS; Invitrogen) and 1ϫ penicillin-streptomycin (100ϫ stock; Invitrogen, CA). Cells were allowed to grow in a T-25 flask, oriented vertically, in a 37°C tissue culture incubator with 5% CO 2 . Cells were split every 2 to 3 days, seeding cells at 5 ϫ 10 5 cells/ml upon passaging and supplementing conditioned media with fresh media to achieve the desired cell density. Cell viability was tested by Trypan blue staining and maintained at Ͼ85%. HL-60 cells were not carried past passage 30.
To differentiate the HL-60 cells to a neutrophil-like state, the cells at Ͼ90% viability were pelleted by centrifugation at 300 ϫ g for 5 min at room temperature. They were resuspended in differentiation media containing RPMI with L-glutamine (Invitrogen, CA) and supplemented with 15% heatinactivated fetal bovine serum (Invitrogen, CA) and 70 mM dimethylformamide (DMF; Fisher). The final cell culture density was 4 ϫ 10 5 cells/ml. Cells were allowed to differentiate for 5 days before harvesting.
NET killing assay. To evaluate the ability of NETs to kill P. aeruginosa strains, either differentiated HL-60 cells or isolated human PMN cells were utilized for NETosis killing assays. HL-60 cells (2 ϫ 10 6 cells/sample) or PMN cells (1 ϫ 10 6 cells/sample) were pelleted, resuspended in one ml of GHBSS ϩϩ buffer in 2-ml microcentrifuge tubes, and stimulated with appropriate amounts of phorbol 12-myristate 13-acetate (PMA; Abcam) for 2 h at 37°C, with agitation by end-over-end rotation (20) . Plated bacterial stocks were inoculated into 5 ml of GHBSS ϩϩ buffer such that the optical density at 650 nm (OD 650 ) was 0.45, resulting in a bacterial suspension of 1 ϫ 10 9 bacteria/ml. Following the 2-h GHBSS ϩϩ incubation, designated neutrophil cell samples were dosed with bacteria at a predetermined multiplicity of infection (MOI), and the samples were incubated at 37°C with end-over-end rotation. Upon completion of the incubation period, all samples were treated briefly (15 min) with MNase I to disperse trapped bacteria. Aliquots of reaction mix were plated before and after MNase I treatment to allow differentiation between the trapped bacteria and killed bacteria (16) . A separate set of samples was treated with endonuclease for the duration of the experiment to serve as a control with no intact NETs. Before plating, samples were diluted in 96-well, V-bottomed microtiter plates using dilution buffer containing DMEM-F12 media (Invitrogen) supplemented with 5% HI-FBS and 0.1% Triton X-100 (MP Biomedicals). Subsequently, 10 l of the diluted samples was spotted onto MacConkey II plates (Becton Dickinson) and allowed to spread in a streak pattern. Preinfection bacterial stocks also were diluted and plated. Plates were allowed to incubate for 10 h at 37°C before colonies were enumerated. The remaining infection supernatants were stored at Ϫ20°C for subsequent analysis.
DNA quantification. PicoGreen double-stranded DNA quantification (Quant-It kit; Invitrogen) was used to determine total DNA content present in bacterial infection supernatants. The assay was performed according to the manufacturer's instructions, and the reaction plate was analyzed by a Tecan Infinite M200 multimode microplate reader. Fluorescence intensity was measured at 520 nm, and a linear-fit model was applied to the standard curve for analysis.
Isolation of NET fragments. Neutrophils were seeded at 2.7 ϫ 10 7 cells/dish onto 10-cm tissue culture dishes in 10 ml RPMI 1640 media (Invitrogen) supplemented with 10 mM HEPES (Invitrogen). Cells were permitted to settle for 30 min at 37°C with 5% CO 2 . Cells were subsequently gently washed three times with culture media and dosed dropwise with prepared bacterial stock. Infection was conducted in a total volume of 10 ml of culture medium. Infection was permitted for 100 min in a stationary tissue culture incubator at 37°C and 5% CO 2 . Following the infection period, NETs from each dish were liberated with appropriate concentrations of MNase enzyme (Thermo Scientific) to yield partial (0.5 U MNase) or complete digestion (20 U MNase) of NET fragments and incubated for an additional 30 min at 37°C. MNase subsequently was inactivated with 5 mM EDTA (Invitrogen) per dish and a 2ϫ final concentration of protease inhibitor cocktail (Roche). Infection supernatants were collected in 15-ml conical tubes, and cell debris was pelleted by centrifugation at 300 ϫ g for 5 min at 4°C. The supernatants were concentrated to 2-ml volumes via spin concentration with Amicon 3,500-molecular-weight-cutoff (MWCO) filter units (Millipore) in a 4°C swingbucket centrifuge at 3,500 ϫ g. Sucrose gradients were assembled at 4°C by addition of 3.2 ml of 50% sucrose (50%, wt/vol, sucrose in HBSS Ϫ/Ϫ ) into a 13.2-ml thin-wall polyallomer ultracentrifuge tube (Beckman Coulter), overlaid with 2 ml of 30% sucrose (30%, wt/vol, sucrose in HBSS
supplemented with 2ϫ protease inhibitor cocktail). The third sucrose layer of 2 ml of 10% sucrose was added, followed by 2 ml of infection reaction supernatants. Assembled gradient samples were ultracentrifuged at 1,600 ϫ g for 22 h at 4°C using an SW41 rotor in a Beckman L8-M ultracentrifuge. Samples were fractionated with a peristaltic pump into 10 1-ml fractions per gradient tube. Fractions were analyzed for DNA via PicoGreen assays and for protein content via Bradford assays (Bio-Rad). Nonstimulated cells were used as background controls.
The protein in each sample was precipitated with trichloroacetic acid (TCA) overnight at Ϫ20°C. Supernatants were carefully removed and washed twice with 100% acetone. The frozen pellets were processed for mass spectrometry analysis at the Taplin Biological Mass Spectrometry Core Facility (Harvard Medical School, Boston, MA). The functional analysis of the proteins identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) was carried out using PANTHER classification and visualized using String v9.05.
Confocal imaging. Corneal washes were cytospun onto lysine-coated slides, fixed with 4% formalin, blocked with 5% goat serum-PBS for 1 h, and stained with anti-mouse histone H4 rabbit IgG (Santa Cruz) overnight at 4°C; slides were washed and developed with goat anti-rabbit Alexa 586 (Invitrogen) and counterstained to visualize DNA with Sytox Green (Invitrogen), per the manufacturer's instructions. Samples were imaged using an LSM 510 META laser scanning confocal microscope (Zeiss, Germany). Alexa 488 was detected using the 488-nm excitation line and a 500-to 530-nm-bandpass filter. Alexa 555 and Alexa 647 were excited at the wavelengths of 543 nm and 633 nm and detected using a 560-to 615-nm-bandpass filter and a 650-nm-long-pass filter, respectively.
OMV production. P. aeruginosa was grown in LB broth until the OD 650 reached 1.2 to 1.6 nm. Cells were removed by centrifugation at 6,000 ϫ g for 10 min. Supernatants were collected and filtered through a 0.22-m Durapore polyvinylidene difluoride (PVDF) filter (Millipore) to remove any remaining bacteria. Outer membrane vesicles (OMVs) were obtained from the cell-free supernatants by centrifugation at 39,000 ϫ g for 1 h and resuspended in HBSS ϩ/ϩ as described previously (21, 22) . OMVs were quantified based on protein levels per density of bacterial culture and visualized using transmission electron microscopy core facility services at the Harvard Medical School core facility.
Statistical analysis. Data were analyzed with GraphPad Prism 5.0 software (GraphPad Software Inc.). Sample distributions were analyzed for normality. When appropriate, data were compared using Student's t test or 1-way analysis of variance (ANOVA), followed by Bonferroni's posttest. P scores of less than 0.05 were considered significant. Proteomic data were compared using chi-squared test. Significance was reported when P values were lower than 0.05.
RESULTS
Cytotoxic P. aeruginosa strains stimulate NET release more than invasive strains. We tested the ability of keratitis-associated P. aeruginosa clinical isolates (the invasive PAO1 and 6294 strains and the cytotoxic PA14 and 6077 strains) to stimulate NET formation ( Fig. 1 ; also see Fig. S1 in the supplemental material). At low MOI, no significant differences were observed in the ability of the strains to trigger eDNA release. At an MOI of 10, the cytotoxic strains 6077 (Fig.  1A) and PA14 (Fig. 1B) induced significantly increased levels of NETosis compared to the invasive 6294 and PAO1 strains. To determine whether those differences were attributed to effector proteins translocated via the type III secretion system, the PAO1 strain that expressed ExoU was used to stimulate NETosis and compared to the parental PAO1 strain or the PA14 strain (Fig. 1A) . ExoU presence conferred an increase in eDNA release.
To verify that the measured eDNA carried the specific markers of NET fibers, NET fragments were released with partial endonuclease (e.g., MNase) cleavage to generate high-molecular-weight (HMW) DNA fragments, and the samples were fractionated over the sucrose density gradient. The individual fractions were analyzed for DNA size, concentration, and neutrophil elastase (NE), a NET protein marker (Fig. 1C and D) (23) . Fractions 1 to 5 contained HMW DNA (Ͼ1 kb), whereas fractions 6 to 9 contained low-MW DNA (Ͻ1 kb). The NE signal was enriched in the HMW DNA-rich fractions of the PA14 and PAO1 ExoU-stimulated samples, indicating the presence of NETs. In contrast, the levels of eDNA released in response to the PAO1 stimulation were minimal, and consequently, the NE signal was low, illustrating that the cytotoxic strain PA14 or ExoU-carrying strain was more efficient at triggering NETosis. These studies were followed by proteomic analysis of NET-associated proteins (see Fig. S2 in the supplemental material). Twenty-eight proteins were shared between the PAO1 strain and the PA14 strain (see Table S1 in the supplemental material). Many of these proteins were identical to previously reported NET-associated proteins, confirming the ability of PA14 to induce NETosis (13, 24, 25) . To functionally prove that the cytotoxic PA14 strain induced NETosis, separate experiments were carried out with differentiated HL-60 cells (used as a model system for neutrophil responses) exposed to P. aeruginosa strain PA14 (MOI, 10) in the presence or absence of DNase I. Based on prior studies, it was expected that the addition of DNase I will fragment NET DNA and liberate active NE (26, 27) . Consistent with this expectation, the extracellular proteome during PA14 infection should be significantly altered in the presence or absence of released NE. The differentially present protein bands were gel extracted and identified by LC-MS/MS (Fig. 2) . DNase I treatment released protease activity that subsequently degraded histones H3 and H4, talin, and actin 1/4. Similar experiments were carried out with purified human neutrophils that were prestimulated to NETose by PMA in the presence or absence of the serine protease inhibitor phenylmethylsulfonyl fluoride (PMSF) (see Fig. S3 in the supplemental material). In these experiments, as in the PA14-stimulated samples, nuclease treatment altered protein presence globally, revealing that PMSF blocked degradation of numerous NET-associated proteins (see Table S2 in the supplemental material). Specifically, the use of the serine protease inhibitor inhibited the loss of NET-associated histones, actin, actin 1/4, ␣-enolase, triose phosphate isomerase, coronin 1A, moesin, and phosphoglycerate mutase but did not affect the levels of myeloperoxidase (MPO), lysozyme, or cyclic AMP.
Distinct susceptibilities of P. aeruginosa strains to NET capture and killing. Based on the proteomic profile of NETs, the expectation was that NETs carry antimicrobial activity. The bactericidal properties of NETs have attracted scientific interest; however, the question of whether NETs are capable of trapping or killing P. aeruginosa remains contentious (14, 16, 28) . To determine the functional significance of NETs, in vitro experiments addressing NET-mediated capture of P. aeruginosa and killing were carried out. In these experiments, neutrophils were pretreated with PMA to induce equal levels of NETosis and exposed to either invasive (e.g., PAO1 or 6294) or cytotoxic (e.g., 6206 or PA14) P. aeruginosa strains in the presence or absence of endonuclease (e.g., MNase) (Fig. 3) . These experiments suggested that NETs aggregated and killed 50% of the invasive strains PAO1 (serogroup O5/O2) and 6294 (serogroup O6), whereas NETs failed to kill the cytotoxic strains 6206 and 6077 (serogroup O11) and PA14 (serogroup O10) (Fig. 3) .
To determine whether the cytotoxic strains escaped NET capture because of changes in the LPS outer core polysaccharide structures, the previously described mutant PAO1 AKA1401 strain that expressed partial B-band LPS was analyzed for NET capture and killing. This strain was captured 25% better than the parental PAO1 strain and was sensitive to NET killing ( Fig. 3 and 4) . These data illustrated that strains with an incomplete O-antigen were slightly more sensitive to NET capture. In a separate series of experiments, a P. aeruginosa PAO1 strain, engineered to express the serogroup O11, termed PAO1R pLPS2 (18) , was analyzed for sensitivity to NETmediated capture and killing. This strain was captured and killed by NETs at 100 or 200 min after exposure to NETosing neutrophils, demonstrating that altering the B-band structure was not sufficient to confer resistance to NETs and did not explain the resistance to NET capture by the cytotoxic strain 6077 or 6206, which belonged to the O11 serogroup (Fig. 4B) .
OMVs inhibit P. aeruginosa adhesion to NETs. To gain insights into the potential mechanism of resistance of the cytotoxic strains to NET capture, the NET-associated bacterial PA14-derived proteome was analyzed. One hundred forty-six bacterially derived proteins copurified with NETs. These proteins could be separated into distinct groups depending on function, including monosaccharide metabolism, protein folding, and protein metabolism ( Fig. 5 ; also see Table S3 in the supplemental material). Based on these findings, we hypothesized that the P. aeruginosa PA14-derived exoproteome competes with bacterial binding to NETs. Prior studies revealed that P. aeruginosa spontaneously, or under stress, produces OMVs (29) . When comparing the recently identified P. aeruginosa PA14 OMV proteome (30) to the NETassociated proteome, 81 proteins were shared (Fig. 5B) . This indicated a significant degree of commonality (P Ͻ 0.0001 by chisquare test). To determine whether P. aeruginosa-produced OMVs competed for NET binding, PA14-derived OMVs were mixed at increasing concentrations with the sensitive strain PAO1. The trapping of PAO1 was significantly inhibited by addition of PA14-derived OMVs (Fig. 5C) . Cumulatively, these data suggest that the cytotoxic PA14 strains escape capture by NETs by releasing OMVs. Notably, the cytotoxic strains secreted higher OMV levels than did the invasive strains even at steady state (Fig. 5D) .
NETs are released at the ocular surface to trap bacteria. Despite the observation that P. aeruginosa induced NETosis in vitro, it was not clear whether NETosis occurred during infection in vivo. To determine whether NETs were produced in vivo during P. aeruginosa-induced keratitis, the ocular surface eDNA was quantified and characterized to determine whether complexes were formed with bacteria. A significant increase in the eDNA was seen at the ocular surface at 48 h after the onset of infection (Fig. 6) . Cytospins of ocular washes showed abundances of clustered bac- cells were exposed to P. aeruginosa PA14 at an MOI of 10, and cellular supernatants were acetone precipitated and resolved on 4 to 15% NuPAGE, followed by LC-MS/MS identification of the differentially present proteins. The plus sign indicates samples that received DNase I treatment during infection, whereas the minus sign denotes nondigested samples. The proteins were identified by LC-MS/MS and are listed next to the bands that were excised for sequencing.
teria attached to the surfaces of NET eDNA fragments covered with histones (Fig. 6) .
To define the biological significance of NETs, exogenous MNase I was applied topically every 8 h after the induction of infection. Topical application of low doses of MNase I decreased bacterial burden and disease pathology, illustrating that the dose of administered MNase I should be carefully monitored, since topical application of high levels of MNase I had toxic effects (Fig. 7) . Consequently, high concentrations of MNase I resulted in the worsening of disease symptoms.
FIG 3
Invasive (6294 and PAO1) and cytotoxic (6206 and PA14) P. aeruginosa strains show distinct sensitivities to NET-mediated capture and killing. Purified human PMNs were pretreated with PMA to induce NETosis and exposed to 6294, PAO1, 6202, and PA14 at an MOI of 0.1 for 100 min. The presence of endonuclease in the reaction mixture is indicated with a plus sign. Results are representative of two independent experiments. Samples were compared using one-way ANOVA for variance, and significant differences are indicated with asterisks. ies that characterize the strain-specific innate and adaptive immunity are needed. In this study, we evaluated the ability of the invasive versus cytotoxic strains to induce NETosis and their relative susceptibilities to NET capture. We found that all strains induced NETosis in vitro. Notably, the cytotoxic strains (e.g., PA14 and 6077) were better at stimulating NETosis than the invasive strains (e.g., PAO1 and 6294), a phenomenon due, at least in part, to ExoU secretion. The cytotoxic strain-induced NETosis was characterized by the typical protein assembly of DNA fibers that included MPO, ␣-enolase, thymidine kinase (TK), etc. (see Table S1 in the supplemental material), as well as active NE (Fig. 2) . The latter was released by limited nuclease treatment and proteolytically degraded NET-associated proteins, thereby facilitating NET clearance. Although the cytotoxic strains were more efficient at inducing NETosis, they were significantly less sensitive to capture, illustrating that these strains hijacked PMN responses by triggering an ineffective neutrophil response. The distinction, highlighted by this study, between invasive and cytotoxic strains of Pseudomonas aeruginosa raises the significant issue of NET evasion mechanisms that are utilized by pathogens. This study demonstrated that cytotoxic Pseudomonas aeruginosa strains were able to evade containment by NETs. These strains, however, are not unique in this capability. For instance, a similar strategy was utilized by N. meningitides to evade capture by NETs (7). These observations suggest that novel therapeutics should target pathways responsible for OMV secretion. Clearly, the identities of the molecular pathways that are induced by PMNs and result in shedding of OMVs by P. aeruginosa should be further characterized to enable pathway-specific targeting.
These studies have implications for vaccine design and therapy. The NET-associated bacterial proteome data have implications for vaccine development. For example, we identified the significant presence of OprF and OprI attached to NETs, illustrating that adhesion to bacteria or P. aeruginosa-derived OMVs is facilitated through these proteins. The outer membrane proteins OprF and OprI are abundant outer membrane porins present on the surface of bacteria and are implicated in OMV formation (30) . Due to their immunogenicity and key bacterial functions, OprF and OprI are vaccine candidates against P. aeruginosa-initiated infections (32, 33) . Current vaccine efforts that utilize recombinant protein composed of OprF and OprI epitopes show that the recombinant vaccine is immunogenic and well tolerated in humans (32) . Our data strengthen the argument that OprF and OprI contribute to the pathogenicity of P. aeruginosa by revealing a novel aspect of OprF and OprI activities, particularly bacterial adhesion.
In addition to OprF and OprI, the remainder of the identified bacterial NET proteome may yield novel vaccine targets. Some of the most abundant proteins adherent to NETs were GroEL, GroES, phosphoglycerate kinase (PGK), DnaK, elongation factor Tu, and elongation factor Ts. Typically, these proteins have intracellular metabolic or chaperone functions, but there is evidence that, when present at the surface, they moonlight to promote bacterial adhesion (34) . For example, DnaK (Hsp70) is a cell surface protein in Listeria monocytogenes, Neisseria meningitides, and Mycobacterium tuberculosis that binds plasminogen, whereas GroEL promotes adhesion of Enterococcus faecalis to actin or actin binding proteins (35) (36) (37) . Interestingly, monoclonal antibody to H. pylori GroEL inhibits the growth of the bacterium, suggesting that there is a connection between the growth control and surface localization of this protein (38) . It is likely that antigen-specific immunity against these adhesion-mediating proteins interferes with bacterial or bacterially derived OMV deposition onto host surfaces.
Our research has direct implications for therapy. Human DNase I, or dornase alfa, has been approved since 1994 for use in cystic fibrosis patients to solubilize dense DNA-containing cystic fibrosis sputum (26, 39) . Our work expands the applicability of recombinant human DNase by demonstrating that nuclease treatment can be used as an adjunctive treatment strategy during acute keratitis to expedite bacterial clearance. However, the levels of administered nuclease should be controlled, as treatment with high levels of DNase has a negative impact on bacterial clearance, most likely through the release of NET-associated active serine proteases like NE. (A) Bacterial P. aeruginosa 6294 presence was quantified 48 h after infection in groups of placebo-treated, 300 U DNase I-treated, and 3,000 U DNase I-treated C57BL/6 mice. (B) Bacterial pathology was scored from 1 to 4 at 48 h after the infectious challenge. Sample values were compared using one-way ANOVA for variance. Significant differences are denoted with asterisks.
